WORK Medical Technology Group LTD (Nasdaq: WOK) ("WORK Medical" or the "Company"), a supplier of medical devices in China, through its subsidiary, Work ...

Candace Owens is intensifying her claims that federal officials helped cover up details in the September killing of Turning ...

President Trump spoke to the country from the White House on Wednesday night, using a prime-time address to highlight his ...

Still, the ban has reset expectations and may reduce harm, and that’s kind of enough Australia's ban on children under 16 holding active social media accounts comes into force on Wednesday. While ...

Vor Biopharma strengthens presence in engineered cell therapy Precision platforms support expanding hematologic treatment design Clinical development enhances visibility across oncology research Vor ...

Vor Biopharma shares fell sharply Tuesday in premarket trading after the company priced its $100 million offering below recent trading prices. Shares traded 31% lower ahead of the morning bell at ...

Vor Biopharma Inc. (NASDAQ:VOR) on Tuesday priced an underwritten public offering of 10 million shares at $10.00 per share. The gross proceeds from the offering are expected to be $100 million. In ...

Vor Biopharma has rebounded from near-delisting by securing global rights (ex-China) to telitacicept, a promising autoimmune therapy. VOR's telitacicept targets multi-billion dollar autoimmune markets ...

VOR Biopharma's valuation surged after in-licensing telitacicept and securing PIPE financing, but capital structure uncertainty persists. Telitacicept's positive phase 3 data in Sjögren's disease ...

German war-themed metal act Kanonenfieber have dropped their new single "Z-Vor!"" just in time for their early-hours set at Summer Breeze Open Air on Thursday night into Friday morning. The track ...

While Vor provided no details on the results, the company is now evaluating a global trial of the drug in the chronic immune condition. Vor hit reset in May, after nearly a decade of work on blood ...